Powering Web3 innovation: Enabling companies integrate Web2 and Web3 worlds
The advent of modern artificial intelligence has ushered in a new era of technological advancement, with large language models (LLMs) at the forefront of this revolution. As businesses and individuals grapple with the challenge of selecting the right AI tool for their needs, three major players have emerged in the LLM space: OpenAI’s GPT, Anthropic’s Claude, and Google’s Gemini.
In today’s rapidly evolving landscape of healthcare, technology plays an increasingly pivotal role in improving patient outcomes, enhancing diagnostics, and transforming treatment methodologies. One such technological innovation that has garnered significant attention is Software as a Medical Device (SaMD).
Every year, millions of people die from heart disease around the world. Early detection and monitoring are crucial for preventing complications and improving patient outcomes. While traditional Holter monitoring has served as a vital diagnostic tool for decades, its limitations have become increasingly apparent. The cumbersome nature of the devices, involving wires and electrodes, often leads to patient discomfort, restricted movement, and potential signal interference, leading to patient non-compliance and inaccurate data collection.